Andale, Neslyn G.
HRN: 26-99-63 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2025
CEFUROXIME 1.5GM (VIAL)
04/21/2025
04/22/2025
IV
1.5gms
Q8hrs
S/P NSVD
Waiting Final Action
04/21/2025
CEFUROXIME 500MG (TAB)
04/22/2025
04/28/2025
PO
500mg
BID
S/P NSVD
Waiting Final Action